Trial
NCT02334319
Ganetespib Window of Opportunity Study in Head and Neck Cancers
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
Synta Pharmaceuticals Corp.
Condition
Stage I Hypopharyngeal Squamous Cell Carcinoma
Intervention
Ganetespib
Why stopped
Lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-07-26